Holdings of NYLIM WMC Small Companies Fund
NYLIM FUNDS TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 343.1M $ including 341.7M $ in equities, 99.6 %
- Positions
- 135 in 8 countries
- Top ten
- 24.2 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 101 | Beam Therapeutics Inc | 15,717 | 401.1K $ | 0.12 % |
| 102 | Supernus Pharmaceuticals Inc | 8,846 | 394.8K $ | 0.12 % |
| 103 | Prestige Consumer Healthcare Inc | 7,677 | 385.5K $ | 0.11 % |
| 104 | Enliven Therapeutics Inc | 6,974 | 382.2K $ | 0.11 % |
| 105 | TARSUS PHARMACEUTICALS INC | 6,417 | 378.9K $ | 0.11 % |
| 106 | Vericel Corp | 8,150 | 374.6K $ | 0.11 % |
| 107 | Immunome Inc | 16,338 | 371.9K $ | 0.11 % |
| 108 | Nektar Therapeutics | 5,242 | 370.5K $ | 0.11 % |
| 109 | Ultragenyx Pharmaceutical Inc | 14,301 | 356.2K $ | 0.10 % |
| 110 | SELLAS Life Sciences Group Inc | 35,280 | 353.2K $ | 0.10 % |
| 111 | ALUMIS INC | 12,388 | 350K $ | 0.10 % |
| 112 | Disc Medicine Inc | 4,541 | 349.7K $ | 0.10 % |
| 113 | VERADERMICS INC | 3,323 | 348.9K $ | 0.10 % |
| 114 | Nurix Therapeutics Inc | 14,618 | 339.3K $ | 0.10 % |
| 115 | VERA THERAPEUTICS INC | 10,278 | 329.9K $ | 0.10 % |
| 116 | BioCryst Pharmaceuticals Inc | 35,864 | 322.1K $ | 0.09 % |
| 117 | Trevi Therapeutics Inc | 17,337 | 316.4K $ | 0.09 % |
| 118 | AMYLYX PHARMACEUTICALS INC | 15,330 | 311.4K $ | 0.09 % |
| 119 | MBX BIOSCIENCES INC | 4,549 | 299.9K $ | 0.09 % |
| 120 | ADMA Biologics Inc | 35,302 | 298.7K $ | 0.09 % |
| 121 | Aurinia Pharmaceuticals Inc | 19,478 | 289.8K $ | 0.08 % |
| 122 | Biohaven Ltd | 21,429 | 289.3K $ | 0.08 % |
| 123 | Agios Pharmaceuticals Inc | 9,372 | 281.3K $ | 0.08 % |
| 124 | Syndax Pharmaceuticals Inc | 14,471 | 275.7K $ | 0.08 % |
| 125 | OCULAR THERAPEUTIX INC | 32,577 | 266.2K $ | 0.08 % |
| 126 | VIRIDIAN THERAPEUTICS INC | 13,961 | 264.1K $ | 0.08 % |
| 127 | PALVELLA THERAPEUTICS INC | 1,892 | 263.1K $ | 0.08 % |
| 128 | Innoviva Inc | 12,469 | 261.5K $ | 0.08 % |
| 129 | ANI Pharmaceuticals Inc | 3,277 | 259.7K $ | 0.08 % |
| 130 | Iovance Biotherapeutics Inc | 63,387 | 258K $ | 0.08 % |
| 131 | Stoke Therapeutics Inc | 8,585 | 247.8K $ | 0.07 % |
| 132 | SAREPTA THERAPEUTICS INC | 15,615 | 232K $ | 0.07 % |
| 133 | Recursion Pharmaceuticals Inc | 77,162 | 231.5K $ | 0.07 % |
| 134 | Intellia Therapeutics Inc | 20,342 | 217.3K $ | 0.06 % |
| 135 | Monte Rosa Therapeutics Inc | 11,273 | 186.2K $ | 0.05 % |
Sector breakdown
- Materials 2.6 %
- Unattributed 97.4 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 97.4 %
- CAD 2.6 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 91.9 %
- Canada 2.9 %
- United Kingdom 1.8 %
- Israel 1.7 %
- Bermuda 1.1 %
- Ireland 0.4 %
- Switzerland 0.2 %
- British Virgin Islands 0.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 126 | 313.9M $ | 91.86 % |
| 2 | Canada | 3 | 10.1M $ | 2.94 % |
| 3 | United Kingdom | 1 | 6.1M $ | 1.79 % |
| 4 | Israel | 1 | 5.7M $ | 1.66 % |
| 5 | Bermuda | 1 | 3.6M $ | 1.05 % |
| 6 | Ireland | 1 | 1.3M $ | 0.39 % |
| 7 | Switzerland | 1 | 706.1K $ | 0.21 % |
| 8 | British Virgin Islands | 1 | 289.3K $ | 0.08 % |
Cite this page
Titelia. "Holdings of NYLIM WMC Small Companies Fund". https://titelia.com/en/funds/S000036715